The association of tumor volume with mortality following radical prostatectomy

Prostate Cancer and Prostatic Diseases

Volumn 17, Issue 2, 2014, Pages 144-148

  Knoedler, J J ^a   Karnes, R J ^a   Thompson, R H ^a   Rangel, L J ^a   Bergstralh, E J ^a   Boorjian, S A ^a  

^a MAYO CLINIC   (United States)

Author keywords

mortality; radical prostatectomy; risk stratification; tumor volume

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SPECIFIC SURVIVAL; CLINICAL EVALUATION; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MARGIN STATUS; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SEMINAL VESICLE; TUMOR INVASION; TUMOR VOLUME; CANCER STAGING; EPIDEMIOLOGY; METABOLISM; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATIC NEOPLASMS; UNITED STATES;

KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; PROSTATE SPECIFIC ANTIGEN;

HUMANS; KALLIKREINS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TUMOR BURDEN; UNITED STATES;

EID: 84901200105     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2013.61     Document Type: Article

References (35)

1. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395-1400
2. Chung BI, Tarin TV, Ferrari M, Brooks JD. Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival. Urol Oncol 2011; 29: 314-318
3. Chun FKH, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 2007; 43: 536-543
4. Epstein JI. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 2011; 186: 790-797
5. Fukuhara H, Kume H, Suzuki M, Fujimura T, Enomoto Y, Nishimatsu H et al. Maximum tumor diameter: A simple independent predictor for biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 2010; 13: 244-247
6. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004; 172: 508-511
7. Salomon L, Levrel O, Anastasiadis AG, Irani J, De La Taille A, Saint F et al. Prognostic significance of tumor volume after radical prostatectomy: A multivariate analysis of pathological prognostic factors. Eur Urol 2003; 43: 39-44
8. Wolters T, Roobol MJ, Van Leeuwen PJ, Van Den Bergh RCN, Hoedemaeker RF, Van Leenders GJLH et al. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol 2010; 57: 821-829
9. Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001; 165: 119-125
10. Thompson RH, Blute ML, Slezak JM, Bergstralh EJ, Leibovich BC. Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? (published erratum appears in J Urol 2007; 178; 2224) J Urol 2007; 178: 459-463
11. Van Der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 2011; 24: 16-25
12. Ates M, Teber D, Gozen AS, Tefekli A, Sugiono M, Hruza M et al. Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy? A matched pair analysis. J Urol 2007; 177: 1771-1775
13. Berger AP, Deibl M, Strasak A, Bektic J, Pelzer A, Steiner H et al. Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: Results from a screening population. Urology 2006; 68: 1067-1071
14. Dvorak T, Chen M-H, Renshaw AA, Loffredo M, Richie JP, D'Amico AV. Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer. Urology 2005; 66: 1024-1028
15. Hong MKH, Namdarian B, Corcoran NM, Pedersen J, Murphy DG, Peters JS et al. Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroup. Pathology 2011; 43: 138-142
16. Manoharan M, Civantos F, Kim SS, Gomez P, Soloway MS. Visual estimate of percent of carcinoma predicts recurrence after radical prostatectomy. J Urol 2003; 170(4 Pt 1): 1194-1198
17. Mizuno R, Nakashima J, Mukai M, Okita H, Kosugi M, Kikuchi E et al. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer. BJU Int 2009; 104: 1215-1218
18. Nelson BA, Shappell SB, Chang SS, Wells N, Farnham SB, Smith Jr JA et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006; 97: 1169-1172
19. Porten SP, Cooperberg MR, Carroll PR. The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease. BJU Int 2010; 105: 472-475
20. Song C, Kang T, Yoo S, Jeong IG, Ro JY, Hong JH et al. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer. Urol Oncol 2013; 31: 168-174
21. Billis A, Meirelles LR, Freitas LL, Polidoro AS, Fernandes HA, Padilha MM et al. Prostate total tumor extent versus index tumor extent-which is predictive of biochemical recurrence following radical prostatectomy? J Urol 2013; 189: 99-104
22. Thompson 3rd IM, Salem S, Chang SS, Clark PE, Davis R, Herrell SD et al. Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: A tale of two methods. World J Urol 2011; 29: 15-20
23. Merrill MM, Lane BR, Reuther AM, Zhou M, Magi-Galluzzi C, Klein EA. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 2007; 70: 294-298
24. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294: 433-439
25. Boorjian SA, Thompson RH, Tollefson MK, Rangel LJ, Bergstralh EJ, Blute ML et al. Long-Term risk of clinical progression after biochemical recurrence following radical prostatectomy: The impact of time from surgery to recurrence. Eur Urol 2011; 59: 893-899
26. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AI (eds). AJCC Cancer Staging Manual. 7th edn. Official Publication of the American Joint Committee on Cancer, 2010
27. Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 2012; 188: 1157-1163
28. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point? J Urol 2001; 165: 1146-1151
29. Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco Jr FJ, Lilja H et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition. J Clin Oncol 2006; 24: 3973-3978
30. Humphrey PA. Tumor amount in prostatic tissues in relation to patient outcome and management. Am J Clin Pathol 2009; 131: 7-10
31. Gallina A, Chun FK, Suardi N, Eastham JA, Perrotte P, Graefen M et al. Comparison of stage migration patterns between Europe and the USA: An analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU Int 2008; 101: 1513-1518
32. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL et al. Early detection of prostate cancer: AUA Guideline. J Urol 2013; 190: 419-426
33. Vollmer RT. Percentage of tumor in prostatectomy specimens: A study of American Veterans. Am J Clin Pathol 2009; 131: 86-91
34. Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. J Urol 2008; 180: 571-576
35. Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 2004; 172: 137-140